The information on this page is intended for journalists, press and media. Click YES to get to the newsroom. If you click NO you will come back to Mynewsdesk.com.
Across the life sciences industry, pharma companies are seeking new ways to respond to the high agility required to produce complex products like personalized cancer treatment, cell and gene therapy and Covid-19 vaccines. Central to these efforts is the manufacturing execution system (MES), which allows pharma companies to adopt pharma 4.0 production and manage their data flows to expedite product
NNIT, a trusted partner of AstraZeneca’s since 2014, will be implementing the critical COVID-19 vaccine post-marketing safety data system.
Orifarm and NNIT have signed a contract for the delivery of end-to-end IT services in connection with Orifarm’s acquisition of a significant portfolio of select over-the-counter (OTC) and prescription pharmaceutical products from Japanese pharmaceutical giant Takeda.
NNIT recently signed its largest Veeva deal to date with a global top-10 life sciences company.
NNIT’s new CFO, Pernille Fabricius, is a change management enthusiast: “I welcome and embrace change, and I enjoy leading an organization through a transformation process to stimulate growth and lasting value across the board. That’s what I’ve been doing throughout my career, and it’s what motivates me”.
NNIT and BA Insight enters new partnership
NNIT acquires US-based Excellis, a leading specialized global provider in end-to-end supply chain consulting services to the life sciences industry.
Following the acquisition of HGP in April 2019 and due legal processes, HGP’s Asia branch recently became NNIT Singapore Pte Ltd.
NNIT extends twelve-year collaboration another four years.
NNIT is ready to help Life Science companies in the United States overcome the challenges they are facing.
New cool Cloud service from NNIT A/S that will benefit all Life Sciences companies. Life Sciences is our DNA: http://bit.ly/2fF0qfR
Pharmaceutical companies will soon be required to submit data in accordance to the ISO IDMP standard in the EU region.Have you initiated the #IDMP readiness phase? Be ready and read more here.
NNIT collaborates with SAP to deliver leading IT software and services for identification of medicinal products (IDMP) tailored to improve the reporting and tracking of product safety.
NNIT today announced the appointment of Jan Weber as General Manager of its North American affiliate. In this role, Jan Weber will lead NNIT’s consolidation as a leading provider of IT services and consultancy for the life sciences sector.
Right now, Danish and European pharmaceutical companies are gearing up to comply with the ISO standards – designated IDMP – that come into force in the EU on 1 July 2016. The ISO IDMP standards require information from many areas of the pharmaceutical business, including regulatory affairs, research and development, manufacturing and distribution.
Following the implementation of XEVMPD, new legislation, based on five new ISO IDMP standards, is due to come into force in 2016. Rune Ringsholm Bergendorff, advanced business consultant at NNIT, explains how pharmaceutical companies will need to adapt business processes across the whole organisation.
When you choose to create a user account and follow a newsroom your personal data will be used by us and the owner of the newsroom, for you to receive news and updates according to your subscription settings.
To learn more about this, please read our Privacy Policy Users, which applies to our use of your personal data, and our Privacy Policy Contacts, which applies to the use of your personal data by the owner of the newsroom you follow.
Please note that our Terms of Use apply to all use of our services.
You can withdraw your consent at any time by unsubscribing or deleting your account
Email sent to __email__. Click the link there to follow NNIT News.
